Obesity Defining Criteria, and Association with Cardiovascular Disease Risk Factors Among People Living with HIV in Jos, Nigeria.
Main Article Content
Keywords
HIV, Obesity, Cardiovascular Disease Risk, Dyslipidaemia.
Abstract
Background: Obesity is linked to non-communicable conditions. We looked at obesity using four definable criteria and their relationship to biochemical and inflammatory indicators of cardiovascular diseases (CVDs) in people living with HIV (PLHIV).
Methodology: This cross-sectional study involved 140 randomly selected HIV-infected patients attending HIV clinics at the Jos University Teaching Hospital and Faith Alive Foundation in Jos, Nigeria. Anthropometric measurements such as height, weight, waist circumference, and hip circumference were taken to identify those with obesity. Fasting plasma glucose, lipid profile, High-sensitivity CRP (hsCRP), and HIV-related markers were evaluated.
Result: The mean (SD) age of the participants was 42.5 (8.8) years, and the majority (71.4%) were females. The prevalence of Obesity based on Body-Mass-Index (BMI), International Diabetes Federation (IDF), Adult Treatment Panel (ATP), and Waist-Hip-Ratio (WHR) criteria were 18.6%, 50.7% 34.3%, and 45.7% respectively. Obesity concordance among the criteria for obesity was highest between IDF and ATP (Kappa= 0.673, p<0.001); and least between BMI vs WHR (Kappa= 0.124, p<0.073). Only 9.3% had obesity by all 4 criteria. BMI was independently associated with hypertension but not glycaemic status nor dyslipidaemia while Obesity by WHR was significantly associated with hypertension and dyslipidaemia, after adjusting for age and sex. There was no significant association between Obesity by all the criteria and HIV-related parameters such as duration of HIV infection, Antiretroviral (ARV) use, and CD4 counts (p>0.05).
Conclusion: Our study urges a unified assessment of obesity and a more prominent use of parameters of central obesity, for assessing cardiovascular risk in PLHIV.
References
2. Tooba R, Wu TD. Obesity and asthma: A focused review. Respir Med. 2022 Nov-Dec; 204:107012.s
3. World Health Organization. Obesity and overweight [Internet]. 2023 [Cited 2023 April 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
4. Zhang, M., Ward, J., Strawbridge, R.J. et al. How do lifestyle factors modify the association between genetic predisposition and obesity-related phenotypes? A 4-way decomposition analysis using UK Biobank. BMC Med 22, 230 (2024).
5. World Obesity Federation. Prevalence of Obesity [Internet]. 2023 [Cited 2023 April 11] Available from: https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity#:~:text=The World Obesity Federation estimates,2030 unless we act soon.
6. Kelly T, Yang W, Chen C s, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International Journal of Obesity. 2008; 32:1431–7.
7. Ajayi IO, Adebamowo C, Adami H olov, Dalal S, Diamond MB, Bajunirwe F, et al. Urban–rural and geographic differences in overweight and obesity in four sub-Saharan African adult populations: a multi-country cross-sectional study. BMC Public Health. 2016; 16 (1126)1–13.
8. 6. Broyles ST, Denstel KD, Church TS, Chaput JP, Fogelholm M, Hu G, et al. The epidemiological transition and the global childhood obesity epidemic. International Journal of Obesity. 2015; Suppl (2015):3–8.
9. Wohlfeiler MB, Weber RP, Brunet L, Siddiqui J, Harbour M, Phillips AL, Hayward B, Fusco JS, Hsu RK, Fusco GP. Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort. AIDS Res Hum Retroviruses. 2023;39(12):636-643.
10. 7. Harvard TH.Chan School of Public Health. Obesity Prevention Source: Obesity Definition [Internet]. 2023 [Cited 2023 April 11] Available from: https://www.hsph.harvard.edu/obesity-prevention-source/obesity-definition/.
11. Harvard TH. Chan School of Public Health. Obesity Prevention Source: Measuring Obesity] Internet]. 2023 [Cited 2023 April 11]. Available from: https://www.hsph.harvard.edu/obesity-prevention-source/.
12. World Health Organization. Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation [Internet]. 2008. p. 8–11 [Cited 2023 April 11] Available from: https://apps.who.int/iris/handle/10665/44583.
13. Thi N, Tran T, Blizzard CL, Luong KN, Le N, Truong V, et al. The importance of waist circumference and body mass index in cross-sectional relationships with risk of cardiovascular disease in Vietnam. PLoS One. 2018;13(5):e0198202.
14. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - A new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469–80.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.
16. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on Epidemiology and Prevention; National Heart, lung, and blood institute; American heart association; World heart federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.
17. Jellinger PS. American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines. Diabetes Spectr. 2018;31(3):234–45.
18. Dobiásová M. AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52(1):64–71.
19. Bo MS, Cheah WL, Lwin S, Nwe TM, Win TT, Aung M. Understanding the Relationship between Atherogenic Index of Plasma and Cardiovascular Disease Risk Factors among Staff of a University in Malaysia. J Nutr Metab. 2018;2018(7027624):1–6.
20. Silber S. Rapid online self-assessment of individual at risk for cardiovascular events in “apparently healthy” persons according to the New ESC Guidelines. E-Journal of Cardiology [Internet]. 2022 [Cited 2024 June 24]. Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-22/rapid-online-self-assessment-of-individual-risk-for-cardiovascular-events-in-a.
21. Aridegbe M, Adeoye I, Oguntade A. Obesity, hypertension, and dyslipidemia among human immunodeficiency virus patients in Abeokuta Ogun State, Nigeria. Niger J Cardiol 2019;16(1):83–91.
22. Ojong E, Iya B, Djeufouata J, Ndeh F, Njongang V, Etukudo M, et al. Metabolic syndrome, and its components among HIV / AIDS patients on Antiretroviral Therapy and ART-Naïve Patients at the University of Calabar Teaching Hospital, Calabar, Nigeria. African Health Sciences. 2022;22(1):410–7.
23. Kemal A, Ahmed M, Teshome MS, Abate KH. Central Obesity and Associated Factors among Adult Patients on Antiretroviral Therapy (ART) in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia J Obes. 2021;2021(1578653):1–10.
24. Muhammad T, Boro B, Kumar M, Srivastava S. Gender differences in the association of obesity-related measures with multi-morbidity among older adults in India: evidence from LASI, Wave-1. BMC Geriatr. 2022;22(171):1–12.
25. Nalugga EA, Laker E, Nabaggala MS, Ddungu A, Batte C, Piloya T, et al. Prevalence of overweight and obesity and associated factors among people living with HIV attending a tertiary care clinic in Uganda. BMC Nutrition. 2022;8(107):1–7.
26. Obry-Roguet V, Brégigeon S, Cano CE, Lions C, Zaegel-Faucher O, Laroche H, et al. Risk factors associated with overweight and obesity in school-age children. Medicine (Baltimore). 2018;97(23):e10956.
27. Dimala CA, Ngu RC, Kadia BM, Tianyi L, Choukem SP. Markers of adiposity in HIV / AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio, and body mass index. PLoS One. 2018;13(3):e0194653.
28. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference, and waist:hip ratio as predictors of cardiovascular risk review of the literature. Eur J Clin Nutr. 2010;64(1):16–22.
29. Dhaliwal SS, Welborn TA. Central Obesity and Multivariable Cardiovascular Risk as Assessed by the Framingham Prediction Scores. Am J Cardiol. 2009;103(10):1403–7.
30. Macaulay S, Dunger DB, Norris SA. Gestational Diabetes Mellitus in Africa: A Systematic Review. PLoS One. 2014;9(6):e97871